New ACR guidelines top vasculitis coverage for Vasculitis Awareness Month
During Vasculitis Awareness Month in May, patient advocacy organizations face the challenge of raising awareness for a rare disease with many different manifestations and states.
This year, the Vasculitis Foundation is sharing stories from patients dealing with this disease each day this month.
In honor of Vasculitis Awareness Month, Healio has compiled five recent stories dealing with vasculitis:
ACR, Vasculitis Foundation guideline emphasizes prompt IVIG for Kawasaki disease
The American College of Rheumatology and the Vasculitis Foundation have released new guidelines for Kawasaki disease, focusing on diagnostic issues, high-risk patients and convalescent patient management. Read more.
Nasal lavage ‘only way’ to bring vasculitis-related chronic sinusitis under control
Treatments for rare complications in vasculitis can range from high-dose prednisone to nasal lavage, according to a speaker at the Congress of Clinical Rheumatology East. Read more.
'Advanced vascular imaging' drives revision to ACR/EULAR vasculitis classification criteria
The American College of Rheumatology and EULAR have updated classification criteria for five types of large- and small-vessel vasculitis, driven in part by advances in diagnostic imaging. Read more.
‘Aggressively’ controlling inflammation, symptoms critical in managing VEXAS syndrome
Staying ahead of inflammation and managing the broad range of symptoms is key to controlling VEXAS syndrome. Read more.
Avacopan bests prednisone for kidney function recovery in ANCA vasculitis
Avacopan yielded significantly better kidney function outcomes than prednisone in a cohort of patients with renal disease associated with anti-neutrophil cytoplasmic antibody vasculitis. Read more.
References:
- @VasculitisFoundation. https://twitter.com/VasculitisFound/status/1521119062591483905. May 2, 2022. Accessed May 24, 2022.